CRISPR Therapeutics AG (CRSP) Return on Sales Growth (3y) (2019 - 2026)
CRISPR Therapeutics AG (CRSP) Return on Sales Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.62 Bn | 4.62 Bn | - | -84.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.00 |
| Dec 31, 2025 | 18,241.00 |
| Sep 30, 2025 | 1,737.00 |
| Jun 30, 2025 | 942.00 |
| Mar 31, 2025 | 33.00 |
| Dec 31, 2024 | 21.00 |
| Sep 30, 2024 | 12.00 |
| Jun 30, 2024 | -245.00 |
| Mar 31, 2024 | -21.00 |
| Dec 31, 2023 | 310.00 |
| Sep 30, 2023 | 623.00 |
| Jun 30, 2023 | 1,810.00 |
| Mar 31, 2023 | 444.00 |
| Dec 31, 2022 | -18,430.00 |
| Sep 30, 2022 | -1,858.00 |
| Jun 30, 2022 | -1,007.00 |
| Mar 31, 2022 | -43.00 |
| Dec 31, 2021 | 403.00 |
| Sep 30, 2021 | -64.00 |
| Jun 30, 2021 | 36.00 |